Imunon, Inc. Investment Owned, at Cost
Imunon, Inc. (IMNN) had Investment Owned, at Cost of $79.08 million as of 2025-07-22, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Schedule of Investments
us-gaap:InvestmentOwnedAtCost · last filed 2026-08-11
- 2025-07-22: Investment Owned, at Cost $79.08M.
| Period end | Investment Owned, at Cost |
|---|---|
| 2025-07-22 | $79.08M 10-Q · filed 2026-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |